Neurocrine Biosciences, Inc. v. Lupin Limited et al
| Neurocrine Biosciences, Inc. |
| Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and Lupin Atlantis Holdings S.A. |
| 1:2022cv01061 |
| August 11, 2022 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 6, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 8
ORAL ORDER Setting Teleconference: IT IS HEREBY ORDERED that a Telephone Conference is set for 10/24/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/6/2022. (dlw)
|
| Filing 7 ANSWER to #6 Answer to Complaint, Counterclaim by Neurocrine Biosciences, Inc..(Balick, Steven) |
| Filing 6 ANSWER to #1 Complaint, , COUNTERCLAIM against Neurocrine Biosciences, Inc. by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings S.A., Lupin Pharmaceuticals, Inc..(Lennon, James) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| No Summons Issued. (lam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc.. (lam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,311,532. (lam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2022. Date of Expiration of Patent: 9/18/2038.Thirty Month Stay Deadline: 10/11/2024. (lam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) |
| Filing 1 Complaint for Patent Infringment against Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-3935481.) - filed by Neurocrine Biosciences, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
